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Chronic low-grade inflammation, particularly in adi-
pose tissue, is an important modulator of obesity-
induced insulin resistance. The Toll-like receptor 4
(Tlr4) is a key initiator of inflammatory responses in
macrophages. We performed bone marrow trans-
plantation (BMT) of Tlr4lps-del or control C57Bl/10J
donor cells into irradiated wild-type C57Bl6 recipient
mice to generate hematopoietic cell-specific Tlr4
deletion mutant (BMT-Tlr4/) and control (BMT-
WT) mice. After 16 weeks of a high-fat diet (HFD),
BMT-WT mice developed obesity, hyperinsulinemia,
glucose intolerance, and insulin resistance. In con-
trast, BMT-Tlr4/ mice became obese but did not
develop fasting hyperinsulinemia and had improved
hepatic and adipose insulin sensitivity during eugly-
cemic clamp studies, compared to HFD BMT-WT
controls. HFD BMT-Tlr4/ mice also showed mark-
edly reduced adipose tissue inflammatory markers
and macrophage content. In summary, our results
indicate that Tlr4 signaling in hematopoietic-derived
cells is important for the development of hepatic and
adipose tissue insulin resistance in obese mice.
INTRODUCTION
Insulin resistance is a major metabolic defect in obesity and is
associated with increased risk of various diseases, such as
type 2 diabetes, hypertension, and coronary heart disease (Fac-
chini et al., 2001). In recent years, chronic, low-grade inflamma-
tion has emerged as an important contributor to the etiology of
insulin resistance in obesity, and because the expansion of
adipose tissue mass is an obvious corollary of obesity, much
research has focused on adipose tissue as a potential site of
this inflammation. Indeed, obese adipose tissue is characterized
by increased expression of inflammatory genes, such as tumor
necrosis factor (TNF)-a, interleukin (IL)-6, regulated upon activa-
tion normal T cell expressed and secreted (RANTES), andmono-
cyte chemoattractant protein (MCP)-1, as well as increased
infiltration by immune cells, particularly macrophages (NguyenCell Met al., 2007; Weisberg et al., 2003; Xu et al., 2003). Macrophages
are an important modulator of inflammation through their
capacity to secrete a variety of proinflammatory chemokines
and cytokines. In fact, adipose tissue macrophages (ATMs)
appear to be responsible for much of the increase in inflamma-
tion in adipose tissue with obesity (Weisberg et al., 2003; Xu
et al., 2003). Consistent with a role for macrophages and inflam-
mation in the pathogenesis of insulin resistance, we have
recently shown that deletion of the two primary inflammatory
pathways in macrophages, namely the inhibitor of IkB kinase/
nuclear factor kB (IKK/NFkB) (Arkan et al., 2005) and c-Jun
NH2 terminal kinase 1/activator protein (JNK1/AP1) (Solinas
et al., 2007) pathways, attenuates obesity-induced insulin resis-
tance. Thus, preventing the propagation of inflammatory signals
within macrophages is sufficient to mitigate obesity-induced
insulin resistance. Nonetheless, the upstream components or
pathways that detect, initiate, and activate the proinflammatory
IKK/NFkB and JNK/AP1 pathways remain to be fully elucidated.
The ‘‘sensors’’ that potentially link obesity to inflammation are
the Toll-like family of receptors (Tlrs); Tlrs are pattern recognition
receptors that play critical roles in innate immunity (Aderem
and Ulevitch, 2000; Wolowczuk et al., 2008). Relevant to obesity
and inflammation, Tlrs, particularly Tlr2 and Tlr4, are highly
expressed in macrophages and adipose tissue. Indeed, we
(Nguyen et al., 2007) and others (Lee et al., 2001, 2003) have
shown that fatty acids (particularly saturated fatty acids) can
activate Tlr2/4, resulting in activation of the IKK/NFkB and
JNK1 pathways, with enhanced secretion of proinflammatory
chemokines and cytokines (e.g., TNF-a). In contrast, in vitro fatty
acid-induced activation of JNK and IKK or induction of proin-
flammatory cytokine expression or secretion is prevented by
small interfering RNA (siRNA)-mediated knockdown of Tlr2/4 in
the RAW264.7 macrophage cell line or in macrophages from
Tlr4 knockout mice (Nguyen et al., 2007; Shi et al., 2006).
Because obesity is characterized by elevated fatty acid levels
(Horowitz et al., 1999; Jensen et al., 1989), the fact that fatty
acids can stimulate a receptor that activates inflammatory path-
ways provides a potentially important link between obesity,
inflammation, and insulin resistance. In support of this, Tlr4
expression is increased in adipose tissue in obesity and in proin-
flammatory macrophages (Nguyen et al., 2007; Shi et al., 2006).
In addition, obesity due to high-fat diet (HFD) feeding and
insulin resistance caused by a lipid-plus-heparin infusion wereetabolism 10, 419–429, November 4, 2009 ª2009 Elsevier Inc. 419
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inflammation in both liver and adipose tissue (Shi et al., 2006;
Tsukumo et al., 2007). However, although these studies clearly
implicate Tlr4 in the development of lipid and obesity-induced
insulin resistance, the specific tissue(s) in which Tlr4 depletion
works to protect mice from insulin resistance remains to be
defined.
Considering the clear role of macrophages in the propagation
of inflammatory signals in adipose tissue and liver (i.e., through
the liver-specific macrophage cell type, the Kupffer cell), we
hypothesized that knockout of Tlr4 signaling in hematopoietic-
derived cells (which includes macrophages) would reduce
obesity-related increases in macrophage infiltration and inflam-
mation and subsequently prevent in vivo insulin resistance. To
address this hypothesis, we generated mice with Tlr4 deleted
exclusively in hematopoietic cells. Our results reveal that mice
deficient in Tlr4 in their hematopoietic compartment are pro-
tected from HFD and obesity-induced insulin resistance, in
parallel with reduced macrophage infiltration in adipose tissue,
reduced chemokine and lymphokine secretion, and a marked
reduction in inflammation in adipose and liver.
RESULTS
Hematopoietic Deletion of Tlr4 Does Affect Peripheral
Lineage Distributions
To generate mice with a complete knockout of Tlr4 in macro-
phages and other immune cells, we transplanted irradiated
wild-type (WT) C57BL6 mice with bone marrow from Tlr4lps-del
(Poltorak et al., 1998) or WT C57BL/10J mice. This adoptive
transfer approach yielded chimeric mice that were deficient in
Tlr4 (BMT-Tlr4/) in all hematopoietic-derived cells but that
had normal Tlr4 expression in all nonhematopoietic tissues
such as skeletal muscle, liver, and adipose tissue. Using this
technique, 8 weeks following bone marrow transplantation
(BMT), > 95%of white blood cells fromBMT-Tlr4/mice lacked
Tlr4 (Figure 1A). Mice transplanted with bone marrow from wild-
type C57BL/10J mice (BMT-WT) displayed normal Tlr4 expres-
sion in all hematopoietic-derived cells and nonhematopoietic
cells/tissues. The loss of Tlr4 did not alter hematopoietic cell
lineage distribution becausemonocyte, lymphocyte, and neutro-
phil counts were normal in the BMT-Tlr4/ and BMT-WT mice
(Figures 1B and 1C), though the proportions of the three cell
types differed slightly between normal chow diet (NCD) and
HFD-fed mice.
Tlr4 Deletion Ameliorates Obesity-Induced
Hyperinsulinemia
As expected, body weight gain in mice fed HFD significantly out-
paced mice fed NCD. There were no significant body weight
differences between BMT-WT or BMT-Tlr4/ mice, and no
differences in food intake were detected (Figures 1D–1G). In
vivo volumetric analysis of body composition using magnetic
resonance imaging (MRI) revealed a comparable increase in
visceral and subcutaneous adipose deposition in HFD versus
NCD mice, irrespective of BMT donor type cells (Figure 1G).
These results demonstrate that the loss of Tlr4 did not affect
the ability of the BMT mice to become obese; moreover, it did
not affect the distribution of fat in the obese animal (Figure 1H).420 Cell Metabolism 10, 419–429, November 4, 2009 ª2009 ElsevieThe percent of weight gain on HFD is nearly identical in the WT
versus the Tlr4/ BMT groups, as is the absolute body weight
gain (9.2 versus 9.0 g, BMT Tlr4/ versus the BMT WT mice).
Because the BMT-Tlr4/ group started at a slightly lower weight
(29.4 ± 1.1 versus 31.3 ± 1.4 g), the absolute body weight at
the end of the 12 week period is slightly (1.7 g) less in the
BMT-Tlr4/ mice. Thus, the BMT-WT and BMT-Tlr4/ groups
are well matched for body weight, obesity, and all other aspects
of adiposity. In contrast, on HFD, bodyweight gain wasmarkedly
reduced in the global Tlr4 knockout mice (i.e., nontransplanted
mice with knockout of Tlr4 in all tissues) compared to WT
controls (Figure 1I). Absolute body weights were 29.3 ± 0.6
versus 28.2 ± 0.7 at week 0 and 32.1 ± 0.9 versus 36.0 ± 0.8 at
week 6, for a weight gain of 2.8 versus 7.8 g in the Tlr4/ versus
WT, respectively. These findings are comparable to the results of
Tsukomo et al. (2007).
The glucose response during a glucose tolerance test (GTT)
was increased in HFD-fed mice, and there were no statistical
differences between the BMT-WT and BMT-Tlr4/ mice
(Figure 2A). On HFD, mice become hyperinsulinemic, but the
insulin response during the GTT was significantly lower in HFD
BMT-Tlr4/ versus BMT-WT mice (Figures 2B and 2C), indi-
cating an overall improvement in insulin action as a result of
Tlr4 deletion from hematopoietic cells. Because both groups
remain glucose intolerant, theremust be a functional b cell defect
in both, but we did not perform further islet studies. We next per-
formed an insulin tolerance test (ITT), which shows that, whereas
HFD caused insulin resistance in BMT-WT mice, the hypogly-
cemic response in the HFD BMT-Tlr4/ group was comparable
to NCD-fed mice (Figure 2D), directly demonstrating protection
from insulin resistance in these mice. Thus, the deleterious
effects of HFD/obesity on glucose metabolism and insulin sensi-
tivity were significantly improved in HFD BMT-Tlr4/mice, sug-
gesting that Tlr4 in immune cells plays an important role in medi-
ating the effects of obesity on insulin action.
Tlr4 Deletion Improves Peripheral Insulin Sensitivity
To further quantify whole-body insulin sensitivity and to better
delineate the tissue-specific site(s) responsible for the improved
glucose homeostasis in BMT-Tlr4/mice, we performed hyper-
insulinemic-euglycemic clamp studies. With this procedure, we
measured the rate of glucose infusion (GINF) that is required to
keep a constant level of blood glucose during a simultaneous
infusion of insulin; the higher the GINF, the greater the overall
insulin sensitivity. The clamp results showed that the GINF that
is required to maintain euglycemia (125 mg/dl) was not signif-
icantly different between NCD-fed BMT-WT and BMT-Tlr4/
mice. As expected, BMT-WT mice fed HFD had markedly
decreased GINF values, confirming insulin resistance. In con-
trast, GINF values were 70% higher in the HFD BMT-Tlr4/
mice compared to BMT-WT (Figure 3A), demonstrating partial
protection from HFD-induced insulin resistance. During the
clamp studies, the steady-state insulin and glucose concentra-
tions were the same between groups.
To determine the contribution of hepatic glucose production,
a simultaneous infusion of tracer-labeled glucose was infused
to provide a measure of the rate of glucose disposal (Rd). Sub-
tracting the GINF from the total Rd yields the endogenous
glucose production rate (mainly from liver). As compared tor Inc.
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Figure 1. Hematopoietic Homeostasis Is Maintained in Mice following Bone Marrow Transplantation of Tlr4-Deleted Hematopoietic Cells
(A) Real-time PCR analysis for the WT Tlr4 genomic locus in peripheral blood mononuclear cells from transplanted mice, demonstrating near complete recon-
stitution of white blood cells in bone marrow transplant recipient mice with Tlr4 deletion mutant hematopoietic cells (BMT-Tlr4/) (n = 8).
(B and C) Hematogram analyses demonstrating normal blood cell lineage distributions, including monocytes, lymphocytes, and neutrophils, in mice (BMT-
Tlr4/), as compared with control mice transplanted with WT Tlr4 (BMT-WT) cells. HFD-fed mice had slightly altered lineage distributions with slightly increased
neutrophil counts and decreased lymphocyte counts, but this was similar for both the BMT-WT and BMT-Tlr4/ mice.
(D–F) Weight gain of mice given HFD or NCD over 12 weeks following BMT, with no statistical difference in weight gain or food intake/day between BMT-Tlr4/
and BMT-WT mice.
(G and H) Cross section and coronal section views using 3Dmagnetic resonance imaging (MRI) of mice and software-based analyses of tissue volumes to deter-
mine the total weight of abdominal adipose tissues and subcutaneous fat tissues demonstrating similar distribution of adipose tissue in the BMT-WT and BMT-
Tlr4/ mice. Red arrows signify visceral fat, and yellow dots signify hepatic tissue.
(I) Weight gain results of a control experiment in which the global Tlr4 knockout mice andWTmice were placed on HFD. Noweight gain was seen in the global Tlr4
knockout mice on a HFD.NCD mice, HFD BMT-WT mice displayed increased basal
hepatic glucose production (HGP) with a markedly impaired
ability of insulin to suppress HGP during the clamp (Figures 3B
and 3C), demonstrating hepatic insulin resistance. In contrast,
in HFD BMT-Tlr4/ mice, basal HGP and insulin suppression
of HGP was completely normalized to values seen in NCD
mice (Figures 3B and 3C). Adipose tissue insulin sensitivityCell Mwas assessed by measuring the percent decrease in plasma-
free fatty acid concentration during the clamp study and was
also normalized in the HFD BMT-Tlr4/ mice (Figure 3D). Con-
sistent with these changes in in vivo insulin sensitivity, we also
observed increased Akt phosphorylation in insulin-stimulated
liver and adipose tissue from the BMT-Tlr4/ mice compared
to BMT-WT controls (Figure 3F). Notably, the HFD-inducedetabolism 10, 419–429, November 4, 2009 ª2009 Elsevier Inc. 421
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(A) The insulin tolerance test (ITT) performed on bonemarrow-transplantedmice reveals a significantly increased insulin sensitivity in BMT-Tlr4/mice fed a HFD
compared to BMT-WT mice also fed HFD.
(B) The glucose tolerance test (GTT) reveals less-efficient glucose clearing over time in obesemice compared to normal weight control mice for either BMT group.
(C and D) The partial correction of insulin levels in obese BMT-Tlr4/mice compared to BMT-WTmice. Area-under-curve analysis of insulin data from (C) shows
a statistical difference between BMT-Tlr4/ and BMT-WT mice both fed HFD.
*p < 0.05 for BMT-Tlr4/ and **p < 0.01 for BMT-WT glucose levels, using Student’s t test.impairment in insulin-stimulated glucose disposal rate (IS-GDR)
in BMT-WT, which primarily reflects skeletal muscle insulin
sensitivity, was not prevented in BMT-Tlr4/ mice (Figure 3E).
Taken together, these data demonstrate that Tlr4 deficiency in
hematopoietic cells prevents HFD-induced glucose intolerance
and insulin resistance, primarily via effects in the liver and
adipose tissue.
The lipid content of liver andmuscle lysates was also analyzed
(Figure 3G).We observed reduced TAG and DAG concentrations
in the livers of Tlr4/BMTmicewith no change inmuscle. These
results are consistent with our findings of increased insulin
sensitivity in liver, but not muscle, in the BMT-Tlr4/ mice. We
did not perform measures of lipogenesis or fat oxidation, and,
although ketone body levels were the same between the two
genotypes (Figure S4 available online), this is a relatively nonspe-
cific assessment of fat oxidation. Therefore, we cannot be sure
whether the decrease in hepatic TAGs and DAGs is due to
increased fat oxidation or decreased lipogenesis.
Inflammatory Cytokine Signaling in Obese HFD
BMT-Tlr4/ Mice
Given that macrophages are the cell type with the highest
surface expression of Tlr4 and, as such, are potent sensors
and effectors for Tlr4-mediated inflammatory responses, we422 Cell Metabolism 10, 419–429, November 4, 2009 ª2009 Elsevieassessed various inflammatory markers in liver, adipose tissue,
and skeletal muscle. Consistent with the MRI data in Fig-
ure 1G, HFD led to an increase in liver weights (Figure 4A).
Because Kupffer cells express CD11b, we demonstrated that
the liver macrophage population (Kupffer cells) was derived
from the transplanted bone marrow by enriching for CD11b-
positive cells using magnetic bead absorption according to the
method of Seki et al. (Seki et al., 2007). Although peripheral blood
mononuclear cells can also express CD11b, the number of these
cells is very low in these liver tissues as determined by the q-PCR
data showing normal Tlr4 content in cells lacking CD11b. More
importantly, CD11b-positive cells were almost completely
devoid of Tlr4 (Figure 4B), indicating near complete replacement
of the recipient Kupffer cells with bone marrow donor-derived
cells. This is in full agreement with the high-level reconstitution
of donor-derived hematopoietic cells seen in the peripheral
blood (Figure 1A).
In liver tissue, mRNA expression analyses of macrophage-
specific immune activators such as IL-1b and F4/80 were signif-
icantly reduced by 60% and 30%, respectively, in HFD BMT-
Tlr4/ versus HFD BMT-WT mice (Figure 4C). Similarly, levels
of other macrophage-expressed inflammatory genes, such as
TNF-a and RANTES (Ccl5), were also significantly reduced
(50% and 70%, respectively). Moreover, immune regulatorsr Inc.
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Figure 3. The Hyperinsulinemic Euglycemic Clamp Test Shows that Obese BMT-Tlr4/Mice Have Normal Insulin Sensitivity of Hepatocytes
and Adipocytes
(A) Glucose infusion rates during clamp test of mice with the BMT-Tlr4/ mice showing partial correction of insulin function as measured by partially restored
glucose infusion rates (n = 8).
(B) The hepatic glucose production (HGP) both at basal levels and during the clamp test. On HFD, HGP in the BMT-Tlr4/mice was not different from HGP on
chow diet, whereas HFD led to an increase in HFP in the BMT-WT group.
(C) The percent of suppression of HGP.
(D) The percentage suppression of free fatty acid secretion from adipose tissue, with obese BMT-Tlr4/mice showing normalized adipocyte insulin sensitivity.
(A–D) *p < 0.05, using Student’s t test. n > 8.
(E) The insulin-stimulated glucose disposal rate (IS-GDR) on NCD or HFD for the two genotypes.
(F) Western blot analyses of adipose and hepatic tissue for makers of insulin signaling. Analysis demonstrates the upregulated phosphorylated Akt in the adipose
and liver of Tlr4/ BMT mice compared to the WT BMT and all mice fed the HFD, suggesting increased insulin sensitivity. Data show representative wells with
tubulin as a loading control.
(G) Lipid analyses of liver andmuscle cell lysates from BMTmice. The triacylglycerol (TAG) and diacylglycerol (DAG) levels were determined via lipid extraction by
organic solvents and separation via thin layer chromatography. Consistent with the in vivo BMT data, in which increased insulin sensitivity was seen in the Tlr4/
mice, liver lysates from these mice showed reduced TAG and DAG. At least eight mice were analyzed per group, and the measurements were averaged from
triplicate wells. Statistical analyses were performed on the samples using Student’s t test. *p < 0.1.such as Nos2, Cxcl1, Cxcl10, andMmp9 tended toward reduced
expression. As a control, the endothelial cell-specific marker
VCAM1 showed no statistically significant change in level of
expression between BMT-WT and BMT-Tlr4/ mice. Comple-
menting the changes in gene expression, the protein content in
liver tissue of TNF-a and RANTES was also significantly reduced
(Figures 4Dand4E) in BMT-Tlr4/mice.Western blot analysis of
c-Jun N-terminal kinase 1 and 2 (JNK1/2) revealed that JNK
signaling was also reduced in the livers and adipose tissues of
HFD-fedBMT-Tlr4/ versusBMT-WTmice (FigureS1). BecauseCell MTNFa and IL-6 stimulate JNKactivity,which can interferewith IRS
and insulin signaling, and tissue levels of these cytokines are
reduced in the BMT-Tlr4/ mice, these results are fully consis-
tent with the enhanced insulin sensitivity in the BMT-Tlr4/
groups. This connection between IL-6, JNK1, and insulin sensi-
tivity is consistent with thework of Sabio et al. (Sabio et al., 2008).
In adipose tissue, the protein amounts of TNF-a, IL-6, and
IL-12p70 were also significantly reduced (Figures 5A and S3).
Because macrophages are an important source of TNF-a and
IL-6 in adipose tissue (Weisberg et al., 2003; Xu et al., 2003), weetabolism 10, 419–429, November 4, 2009 ª2009 Elsevier Inc. 423
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Figure 4. Insulin Sensitivity in Hepatocytes of ObeseMice Correlates with Reduced Inflammatory Signaling of Tlr4/Hepatic Macrophages
(A and B) CD11b livermacrophages (predominantly Kupffer cells) play an important role in regulating inflammation in the liver. (A) and (B) show the increase in liver
weight of HFD-fed mice compared to NCD mice and the near complete reconstitution of CD11b-positive cells of the Tlr4/ genotype in the liver of obese mice
following bone marrow transplantation. Homogenized liver tissue from bone marrow-transplanted mice was enriched for the macrophage-specific marker
CD11b, and real-time PCR was performed to assay for wild-type Tlr4 genomic DNA content.
(C) The fold reductions of macrophage-specific and nonspecific proinflammatory cytokines, chemoattractants, and signaling molecules of BMT-Tlr4/ mice
compared to BMT-WT mice fed a HFD.
(D and E) Levels of TNF-a and the chemoattractant RANTES via ELISA.measured macrophage infiltration in adipose tissue from HFD
BMT-WT and BMT-Tlr4/ mice. Analysis of adipose tissue
from HFD BMT-WT mice demonstrated increased staining with
the macrophage-specific antibody, MAC2, as compared to
NCD mice (Figure 5, compare 5C and 5E). Of interest, this was
markedly reduced in BMT-Tlr4/mice (Figure 5F), as measured
by the number of crown-like structures (macrophages) present in
the extracellular space between adipocytes. These findings are
consistent with the aforementioned reductions in gene expres-
sion and protein content of proinflammatory signaling molecules
in both liver and adipose tissue.
Lentiviral Knockdown of Tlr4 in HFD Mice
To verify the importance of hematopoietic Tlr4 in mediating
obesity-induced insulin resistance in mice, we utilized a novel
approach, employing a lentiviral vector to knock down Tlr4 in
autologous hematopoietic stem cells. Bone marrow hematopoi-
etic and progenitor cells fromWTC57Bl6 donormicewere trans-
duced in vitro with lentiviral vectors expressing a siRNA targeted
against endogenous Tlr4 (LV-siTlr4) or a control vector. To
ensure high-level transduction efficiency in the bone marrow
cells, we included the marker gene GFP in both vectors. Trans-
duced cells were then transplanted into irradiated C57Bl6 recip-424 Cell Metabolism 10, 419–429, November 4, 2009 ª2009 Elsevieients, and after 8 weeks for bone marrow reconstitution, bone
marrow cells from these primary BMT mice were then sorted
by flow cytometry for GFP expression. Using this approach,
the GFP-positive cells represent the bone marrow cell popula-
tion that was successfully and stably transduced with the
LV-siTlr4 or control vector. We then transplanted these GFP-
positive bone marrow cells into irradiated C57Bl6, secondary
recipient mice. Endogenous levels of Tlr4 in peripheral blood
cells were knocked down by 80% in LV-siTlr4 mice, as com-
pared to control LV-GFP mice (Figure 6A). As expected, on
HFD, both transplanted mouse groups gained a comparable
amount of body weight (Figure 6B). On NCD, both the LV-siTlr4
mice and the control vector mice displayed insulin sensitivity
during ITTs (Figure 6C). When the same mice were placed on
HFD, the LV-shTlr4 mice retained normal insulin sensitivity,
whereas the control vector mice became insulin resistant (Fig-
ure 6D). These results confirm the role of hematopoietic Tlr4
expression in obesity-induced insulin resistance.
DISCUSSION
Although recent evidence shows that chronic inflammation is
a central contributing factor in the development of insulinr Inc.
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matory signal in obesity are unclear. Here, we show that, in
hematopoietic cells, knockout of Tlr4, which is a key receptor
involved in activation of the innate immune/inflammatory
response, prevents HFD/obesity-induced hyperinsulinemia,
hyperglycemia, and abrogates insulin resistance in liver and
adipose tissue. Importantly, the improved insulin action in adi-
pose tissue and liver of these mice occurred in conjunction
with reduced macrophage infiltration of adipose tissue, as well
as reduced expression of proinflammatory cytokines, such as
TNF-a, both in adipose tissue and liver. We further verified the
importance of hematopoietic cell Tlr4 in the induction of insulin
resistance by using a gene therapy approach to knock down
Tlr4 in autologous hematopoietic stem cells. Considering that
Tlr4 is a receptor for fatty acids, our results suggest that Tlr4
acts as an important transducer of the extracellular signal from
fatty acids to activation of intracellular inflammatory pathways
in hematopoietic cells (most likely macrophages), with subse-
quent release of proinflammatory cytokines that cause insulin
resistance.
Chronic low-grade tissue inflammation has recently garnered
considerable attention as a necessary contributor to insulin
resistance in obesity. Tlrs play a critical role in activating the
innate immune response and, consequently, have been impli-
cated in the induction of insulin resistance in obesity. Tlr4 is an
attractive candidate for linking innate immunity to insulin resis-
tance because it is expressed in most cell types and Tlr4 is
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Figure 5. Reduced Inflammatory Cell
Recruitment to Adipose Tissue in BMT-
Tlr4/ Mice on HFD
(A) Decreased expression of common proinflam-
matory cytokines in adipose tissue of BMT-Tlr4/
mice compared to BMT-WT mice fed a HFD.
(B–F) Histological analysis of adipose tissue
stained with MAC2 antibody for macrophage
detection. Significantly increased macrophage
infiltration between adipocytes is detectable and
visually quantitated as crown-like structures with
significant reductions in BMT-Tlr4/ mice
compared to BMT-WT mice fed HFD.
*p < 0.05 for BMT-Tlr4/ and p < 0.01 for BMT-
WT, using Student’s t test.
also a receptor for fatty acids, which are
increased in obesity (Lee et al., 2001,
2003). Indeed, several recent studies
have demonstrated that mice with
knockout of Tlr4 (Shi et al., 2006) or
a loss-of-function mutation in Tlr4 (Tsu-
kumo et al., 2007) are protected against
fatty acid- and obesity-induced insulin
resistance. However, because Tlr4 is
expressed in many important insulin-
responsive cell types (e.g., muscle, adipo-
cytes, and hepatocytes), a limitation of
these studies is that they do not specifi-
cally isolate the contribution of the
innate immune system (e.g., macro-
phage, neutrophils, etc.) to changes in insulin sensitivity. To
address this and other questions, we used BMT to generate
chimeric mice with knockout of Tlr4 specifically in hematopoietic
cells. Because innate immune cells are derived from hematopoi-
etic stem cells, our model results in the knockout of Tlr4 in
macrophages, as well as in other hematopoietic cells. Of
interest, our results demonstrate that BMT-Tlr4/mice are pro-
tected against HFD/obesity-induced hyperinsulinemia, insulin
intolerance, and insulin resistance in adipose tissue and the liver.
These results are in line with recent studies in which we found
that myeloid-specific knockdown of JNK1 (which is a down-
stream target of Tlr4 signaling) and IKK improve insulin sensitivity
in HFD-fed mice.
Two previous studies have examined the issue of insulin resis-
tance in mice in which Tlr4 is either knocked out or disabled
(Shi et al., 2006; Tsukumo et al., 2007). In the paper by Shi et al.
(Shi et al., 2006), the authors show that the Tlr4 knockout
protects animals from the effects of acute lipid infusions to cause
insulin resistance; however, the tissues that are responsible for
this systemic effect could not be specified. This finding during
acute lipid infusions did not translate that well into the setting
of chronic HFD. Thus, they found that the Tlr4 deletion had no
effect on body weight or insulin sensitivity in HFD-fed male
mice but did lead to increased obesity with insulin sensitivity in
females. In contrast, Tsukomo et al. (Tsukumo et al., 2007)
studied mice with a loss-of-function Tlr4 mutation and found
that male animals gained less body weight than controls onCell Metabolism 10, 419–429, November 4, 2009 ª2009 Elsevier Inc. 425
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Figure 6. Lentiviral Vector-Mediated Knockdown of Tlr4 in a Hematopoietic Stem Cell Gene Therapy Setting Maintains Insulin Sensitivity in
HFD Mice
(A) Lentiviral vector driving expression of siRNA targeted against Tlr4 in bonemarrow-transplantedmice of transduced and sorted hematopoietic stem cells yields
partial but significant knockdown of Tlr4 expression in peripheral blood mononuclear cells of transplanted mice as determined by real-time PCR. n = 3.
(B) Average weights of mice fed either a HFD or a NCD.
(C and D) ITT was performed at 8 weeks posttransplant with LV-siTlr4 and control vector-transduced bone marrow mice receiving NCD (C) or HFD (D).HFD and became less insulin resistant. However, in the setting of
a lean and insulin-sensitive phenotype, it is not clear whether it is
the leanness of the mouse or the knockout of Tlr4, per se, that
causes the insulin sensitivity, and the tissue type that is respon-
sible for the phenotype could not be determined. Because our
chimeric mice express Tlr4 deficiency only in bone marrow-
derived hematopoietic cells, both control and knockout mouse
models gained an equal amount of weight on HFD and had equal
expansion of both subcutaneous and visceral adipose depots.
Thus, differences in adiposity between our two groups (BMT-
WT and BMT-Tlr4/) are not a confounding factor, making it
possible to ascertain the contribution of hematopoietic cell Tlr4
signaling to insulin sensitivity. It is not clear why the Shi et al.
and Tsukumo et al. studies are so different from each other,
but perhaps it is due to the fact that one group studied Tlr4 null
animals (Shi et al., 2006), whereas the other studied a mouse
strain carrying a loss-of-function mutation in the Tlr4 receptor
(Tsukumo et al., 2007). Of course, other strain differences may
also be contributing factors. Clearly, the animal model that we
used is much different because we employed adoptive transfer
to generate chimeric animals all on the same background in
which the Tlr4 depletion is only carried in hematopoietic-derived
cells with normal Tlr4 in all other tissues.
It is of interest that, although we found substantial effects of
the hematopoietic Tlr4 knockout to cause systemic insulin sensi-
tivity, these effects were primarily manifested in liver and adipose426 Cell Metabolism 10, 419–429, November 4, 2009 ª2009 Elseviertissue. With respect to skeletal muscle, we did not observe
changes in the insulin-stimulated in vivo glucose disposal rate,
and because 70%–80% of in vivo insulin-stimulated glucose
disposal is into skeletal muscle, this implies no major changes
in skeletal muscle insulin sensitivity. It is well known that, on
HFD, large increases in macrophage numbers occur in adipose
tissue and that, in the liver, Kupffer cell inflammatory activation
state is enhanced and the number of Kupffer cells may also be
increased. On the other hand, there are relatively few macro-
phages that appear in skeletal muscle on HFD, and these cells
are mostly present in intermuscular adipose deposits. Because
inflammatory markers were markedly decreased in liver and
adipose tissue of the BMT-Tlr4/ mice, the data indicate that
Tlr4 expression in hematopoietic-derived cells is an important
control point for HFD-induced inflammation in adipose tissue
in liver. In skeletal muscle, it is possible that the Tlr4 on the
muscle cell itself plays the major role in detecting lipid signals
in the setting of HFD-induced skeletal muscle insulin resistance.
Indeed, Tsukomo et al. provide evidence for this hypothesis
because they have directly shown that, when studied ex vivo,
Tlr4 knockout muscle is protected from fatty acid-induced
insulin resistance. This is consistent with our own results in
which we show that deletion of hematopoietic cell Tlr4 is suffi-
cient to cause a systemic insulin-sensitive phenotype but that
this was primarily manifested in liver and adipose tissue and
not muscle.Inc.
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Tlr4 KO BMT Ameliorates Insulin ResistanceTlr4 in macrophages is necessary for activation of inflamma-
tory pathways by fatty acids or lipopolysaccharides (LPS).
Knockdown of Tlr2 and/or Tlr4 in macrophage cells attenuates
fatty acid-induced activation of Jnk1 and abrogates TNF-a
secretion into the media. In fact, JNK1 is an obligatory compo-
nent for the ability of fatty acids and Tlr4 to activate inflammatory
pathways and to increase TNF-a secretion (Nguyen et al., 2007).
In support of these findings, we found that the expression of
several proinflammatory cytokines, namely, IL-6, TNF-a, and
IL-12 p70, was markedly reduced in adipose tissue from BMT-
Tlr4/ mice on HFD. It is likely that the reduced expression of
TNF-a is directly related to the reduced macrophage infiltration,
as macrophages are the primary source of TNF-a in obese
adipose tissue (Weisberg et al., 2003; Xu et al., 2003). It is notable
that IL-12 p70 was reduced in our mice because IL-12 is impor-
tant for the transition of naive T cells into Th1 cells (Hsieh et al.,
1993). This is relevant to our studies because the main targets
of Th1 cells are macrophages, whereby Th1 cells act to induce
a macrophage proinflammatory state. Thus, we hypothesize
that Tlr4 is an obligate receptor for the transduction of an
obesity-derived signal (i.e., increased fatty acids) to macro-
phages. In turn, activation of inflammation via macrophage Tlr4
potentiates recruitment of additional cells to adipose tissue,
with subsequent polarization to a proinflammatory state. This
feed-forward process is likely exacerbated by the fact that Tlr4
expression is increased in macrophages in obese adipose tissue
(Nguyen et al., 2007). Consistent with this, insulin’s effect to
suppress circulating FFA levels was much greater in the BMT-
Tlr4/ mice, indicative of improved adipose insulin action.
In the liver, macrophages are present in the form of Kupffer
cells. Because Kupffer cells are bonemarrow derived, our model
allows us to determine the effect of Tlr4 in Kupffer cells on induc-
tion of inflammation (and insulin resistance) in the liver of obese
animals. Similar to results in adipose tissue, we found that the
expression of various proinflammatory markers was markedly
reduced in the liver of BMT-Tlr4/ mice. In fact, the HFD-
induced increase in TNF-a and RANTES in liver was completely
reversed in BMT-Tlr4/ mice. In parallel with this decrease in
inflammation, the ability of insulin to suppress HGP in BMT-
Tlr4/ mice was normalized to values seen in chow-fed mice.
These results suggest that activation of inflammatory pathways
in immune cells in the liver is necessary for induction of hepatic
insulin resistance on HFD.
We extended these findings by demonstrating that transplan-
tation of mice with bone marrow containing lentiviral-driven
siRNA knockdown of Tlr4 leads to improved insulin sensitivity
on HFD. Of interest, this occurred despite the fact that we did
not achieve as high a level of knockdown as seen in the BMT-
Tlr4/ mice (>95% versus 80% knockdown for BMT-Tlr4/
and LV-siTlr4, respectively), suggesting that complete knock-
down of Tlr4 is not necessary in order for beneficial metabolic
effects to occur.
During the review of this manuscript, Coenen et al. (Coenen
et al., 2009) published a paper using the BMT-Tlr4/ approach
and reported a decrease in ATM content with reduced markers
of adipose tissue inflammation on HFD in the KO mice. They
also found a decrease in atherosclerosis in the KO mice, but
no changes in glucose homeostasis. However, this study con-
sisted of only female mice of the LDL KO background, andCell Mtheywere nonobese Agouti animals and, thus,markedly different
than those in the current study.
In summary, we have demonstrated that knockout of Tlr4
signaling in macrophages reverses insulin resistance in adipose
tissue and liver in HFD-fed obese mice. This protection occurs in
parallel with a marked reduction in macrophage infiltration in
adipose tissue and reduced inflammatory markers in adipose
and liver. Altogether, these data indicate the importance of
innate immunity and hematopoietic-derived cells, particularly
macrophages and Kupffer cells, in the induction of insulin resis-
tance in obesity. Our data also identify Tlr4 in hematopoietic-
derived cells as a potential target for the therapeutic treatment
of insulin resistance.
EXPERIMENTAL PROCEDURES
Bone Marrow Transplantation
Murine total bone marrow hematopoietic progenitor donor cells were har-
vested fromWT or Tlr4lps-del C57B10 mice (Jackson Laboratories, Bar Harbor,
ME) andwere transplanted via tail vein injection into lethally irradiated C57Bl6J
mice (1100 rads; Cobalt-60 source) with a minimum cell dose of 106 mononu-
clear cells, or 100,000 lineage-depleted cells per mouse. Transplanted mice
were housed in microisolator housing for 6 weeks prior to challenge with
HFD and subsequent insulin sensitivity analyses. For experiments in which len-
tiviral vectors were used to knock down Tlr4, bone marrow from wild-type
CD45.1 mice (backcrossed to C57Bl6J mice; Jackson Laboratories) was
lineage depleted for hematopoietic progenitor cell enrichment (as per manu-
facturer’s instruction, Stem Cell Technologies, Vancouver, BC). Transduction
of the progenitor and stem cells was performed as described below.
Lentiviral Vectors
The third-generation lentiviral vectors used in these studies have been
described but, in brief, contain the self-inactivating deletion and an internal
CMV promoter driving the marker gene GFP (Dull et al., 1998). The siRNA
cassette directed against Tlr4 and driven by human H1 Pol III promoter was
placed upstream of theCMV promoter (cloning details provided upon request).
Lentiviral vector supernatants were prepared as previously described (Miyoshi
et al., 1998).
Transduction
The protocol for efficient transduction of lineage-depleted hematopoietic stem
cells and progenitors has been previously described (Woods et al., 2006). In
brief, transduction conditions involved 2 days of prestimulation in serum-free
expansion medium (SFEM) with 50 ng/ml of each stem cell factor, thrombo-
poietin, and flt-3 ligand (Stem Cell Technologies, Vancouver, BC), followed
by a high multiplicity of infection transduction of blood cells by pelleting up
to 500,000 cells and resuspending30–100 ml of concentrated viruswith a titer
greater than 109 HeLaTU/ml and the volume of virus adjusted to ensure
a minimum of 100 infectious units per cell. Incubation was for 1 hr, followed
by addition of 150 ml of SFEM medium and cytokines overnight. A second
hit was then performed using an additional 30–50 ml of high titer virus directly
to the cells in medium and incubated an additional night. All incubations are
performed at 37C with 5% CO2. Expansion during 4 day transduction was
2- to 3-fold.
Metabolic Studies
Insulin tolerance tests (ITT) were performed pre- and postdiet and following
Tlr4 knockdown in all groups of animals. ITT testing allowed us to determine
the effectiveness of insulin to reduce fasting glucose levels. In brief, mice
were fasted 6 hr, and blood glucose concentrations were assessed before
the injection of 0.5 U/kg insulin (intraperitoneal injection) and then 10, 15, 20,
30, 45, 60, and 90 min following injection. At each time point, a 5 ml blood
sample was collected via tail nick, and glucose was assessed with LifeScan
OneTouch glucose monitoring system. At 1 week later, the same group of
animals was subjected to a glucose tolerance test (GTT). Here, animals were
fasted 6 hr, and blood glucose concentrations were assessed before andetabolism 10, 419–429, November 4, 2009 ª2009 Elsevier Inc. 427
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(454 mg/ml).
Hyperinsulinemic-Euglycemic Clamp
Hyperinsulinemic-euglycemic clamps were conducted to determine insulin-
stimulated glucose disposal rate (IS-GDR) and the inhibitory effect of insulin
on hepatic glucose production (HGP). In brief, mice were anesthetized with
ketamine (80 mg/kg), acepromazine (0.5 mg/kg), and xylazine (16 mg/kg) via
IP injection. The jugular vein was cleared of surrounding tissue, and twomicro-
urethane catheters (Type MRE-025) were advanced1 cm into the vessel and
secured with 4-0 silk suture. The catheters were tunneled to the midscapular
region and externalized. The skin was closedwith 6-0 suture, and the catheters
were secured within silastic tubing (0.078’’ ID 3 0.125’’ OD) that had been
externalized and secured to the skin with 6-0 silk suture. The mice were
allowed to recover for 5 days before undergoing the clamp protocol. Following
a 6 hr fast, blood glucose was assessed via tail nick, body mass was
measured, and themice were placed in a Lucite restrainer (Braintree Scientific,
Braintree, MA). Once in the restrainer,75 ml of whole blood was collected for
the assessment of plasma insulin and free fatty acids (at t = 60 min). Equili-
brating tracer solution (41.6 mCi 3H/ml at 2 ml/min) was infused intravenously
for 60 min. At the end of the equilibration period (t = 0 min), 2 3 15 ml of whole
blood was collected, and blood was deproteinized for the assessment of
tracer specific activity and basal glucose disposal rate. Following the equilibra-
tion period, a cocktail containing 8% BSA, insulin, and tracer was infused at
a constant rate (6.0 mU/kg/min and 41.6 mCi/ml at 2.0 ml/min) along with a vari-
able glucose infusion (50% dextrose, 454 mg/ml). Blood glucose was
assessed every 10min for determination of glucose infusion rate. Glucose infu-
sion rate was adjusted until steady-state blood glucose (120 mg/dl, ± 5 mg/dl)
was achieved. The clamp was terminated when steady-state conditions were
maintained for R 30 min (120 min), at which time 2 3 15 ml of blood was
collected for assessment of tracer-specific activity and insulin-stimulated
glucose disposal rate (t =120min). At the end of the clamp period, themouse
were exsanguinated by cardiac puncture (R1 ml, whole blood collected), and
tissues were harvested, mass recorded, and preserved as required for future
analysis.
Tissue Collection and Analysis
At the end of each clamp study, muscle, liver, and fat tissues were harvested
for measuring of the mRNA and protein content of insulin-signaling molecules
and inflammatory-signaling molecules. Real-time RT-PCR was performed
using ABI systems 9600 thermal cycler (primers sequences available upon
request). MRI analyses, including adipose volume determinations, were per-
formed using UCSD functional MRI core facility using the 7T system (21 cm
bore, Bruker Avance II console). Adipose tissue immunohistochemistry was
performed via cryostat sectioning followed by staining with Mac2 antibody
(BD PharMingen) with analysis of crown-like structures as defined previously
by Murano et al. (Murano et al., 2008). Kupffer cell-enriched fractions were
prepared from collagenase and pronase digested livers using CD11b
magnetic beads (Seki et al., 2007).
The triacylglycerol (TAG) and diacyglycerol (DAG) levels in liver and muscle
cell lysates were determined using 50–100 mg of tissue, subjected to lipid
extraction by organic solvents as previously described by Bligh and Dyer
(1959) and Folch et al. (1957). The organic solvent layer containing extracted
lipids was dried and dissolved in 0.1 ml chloroform. TAG and DAG were sepa-
rated by thin layer chromatography (TLC) and extracted from silica gel by chlo-
roform/methanol. For TAG determination, solvent was evaporated and TAG
was resuspended by sonication in TBS containing 0.1% NP-40. The amount
of TAG was determined by a commercial kit from WAKO Diagnostic, which
measures glycerol level released after hydrolysis of TAG by a lipase. For
DAG determination, evaporated lipids were saponified by 1 M KOH for 1 hr
at 55C, and the mixture was neutralized by 2N HCl. Glycerol level released
by hydrolysis of DAG was measured by the same WAKO kit above.
Westerns were performed using 4%–12% SDS-PAGE acrylamide gels (Invi-
trogen, CA). The phospho-JNK antibody that was used targets the threonine
308 amino acid residue. All antibodies were purchased from Cell Signaling
Technology (MA).
BioPanel analysis of inflammatory markers in serum from BMT mice for
Figure S2 (plasma insulin, leptin, resistin, MCP-1, and plasminogen activator428 Cell Metabolism 10, 419–429, November 4, 2009 ª2009 Elsevieinhibitor [PAI-1]) were measured with a multiplex adipokine assay kit
(MADPK-71K, Millipore) according to the instructions of the manufacturer.
The multiplex adipokine assays were performed by using a Luminex 200
MAP system (Luminex Technology).
SUPPLEMENTAL DATA
SupplementalData include fourfiguresandcanbe foundwith thisarticleonlineat
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